Hai cercato la traduzione di selektivni modulator estrogenskih... da Sloveno a Inglese

farmakoterapevtska skupina: selektivni modulator estrogenskih receptorjev (serm); oznaka atc: g03xc02.
pharmacotherapeutic group: selective estrogen receptor modulator, atc code: g03xc02.

zdravilna učinkovina zdravila optruma, raloksifen, je selektivni modulator estrogenskih receptorjev (serm).
the active substance in optruma, raloxifene, is a selective oestrogen receptor modulator (serm).

zdravilna učinkovina zdravila raloxifene teva, raloksifen, je selektivni modulator estrogenskih receptorjev (serm).
the active substance in raloxifene teva, raloxifene, is a selective oestrogen receptor modulator (serm).

abatacept je prvi selektivni modulator kostimulacije.
abatacept is the first selective co-stimulation modulator.

zdravilna učinkovina v zdravilu esmya, ulipristalacetat, je selektivni modulator progesteronskih receptorjev.
the active substance in esmya, ulipristal acetate, is a ‘selective progesterone receptor modulator’.

pripada skupini zdravil, ki se imenujejo selektivni modulatorji estrogenskih receptorjev (serm).
it belongs to a group of medicines called selective estrogen receptor modulators (serm).

fareston ni priporočljiv za bolnice s tumorji brez estrogenskih receptorjev.
fareston is not recommended for patients with estrogen receptor negative tumours.

bazedoksifen deluje primarno kot antagonist estrogenskih receptorjev v tkivih maternice in dojk.
bazedoxifene functions primarily as an oestrogen-receptor antagonist in uterine and breast tissues.

fulvestrant je kompetitivni antagonist estrogenskih receptorjev z afiniteto, primerljivo z afiniteto estradiola.
fulvestrant is a competitive estrogen receptor (er) antagonist with an affinity comparable to estradiol.

8 informacije o varnosti, povezane s farmakološko skupino abatacept je prvi selektivni modulator kostimulacije.
safety information related to the pharmacological class abatacept is the first selective co-stimulation modulator.

ulipristalacetat je peroralno delujoči, sintetični selektivni modulator progesteronskih receptorjev, za katerega je značilen za tkivo značilni, delni progesteronski antagonistični učinek.
ulipristal acetate is an orally-active synthetic selective progesterone receptor modulator characterised by a tissue-specific partial progesterone antagonist effect.

mehanizem delovanja fulvestrant je kompetitivni antagonist estrogenskih receptorjev z afiniteto, primerljivo z afiniteto estradiola.
mechanism of action fulvestrant is a competitive estrogen receptor (er) antagonist with an affinity comparable to estradiol.

ospemifene sodi v skupino zdravil, ki ne vsebujejo hormonov, imenovanih selektivni modulatorji estrogenskih receptorjev (serm, selective estrogen receptor modulators).
ospemifene belongs to a group of medicines that do not contain hormones called selective estrogen receptor modulators (serms).

ta se veže na estrogenske receptorje na površini celic, kjer zavira učinke hormona in zmanjša število estrogenskih receptorjev.
it attaches to the receptors for oestrogen on the surface of cells, where it blocks the effects of the hormone and causes the number of oestrogen receptors to fall.

ta se veže na estrogenske receptorje na površini celic, kjer blokira učinke hormona in povzroča zmanjšanje števila estrogenskih receptorjev.
it attaches to the receptors for oestrogen on the surface of cells, where it blocks the effects of the hormone and causes the number of oestrogen receptors to fall.

bazedoksifen deluje kot oboje, agonist ali antagonist estrogenskih receptorjev, odvisno od vrste celic in tkiva in pa tarčnih genov.
bazedoxifene acts as both an oestrogen-receptor agonist and/or antagonist, depending upon the cell and tissue type and target genes.

dodajanje bazedoksifena, ki deluje kot antagonist estrogenskih receptorjev v maternici, znatno zmanjša z estrogeni povezano tveganje hiperplazije endometrija pri nehisterektomiranih ženskah.
the addition of bazedoxifene, acting as an oestrogen receptor antagonist in the uterus, greatly reduces the oestrogen-induced risk of endometrial hyperplasia in non-hysterectomised women.

chmp je menil, da je varnostni profil zdravila senshio, ki so ga preučevali do 15 mesecev, skladen z zdravili, ki delujejo na podoben način (selektivni modulatorji estrogenskih receptorjev).
the chmp considered that the safety profile of senshio, which was studied for up to 15 months, was in line with medicines working in a similar way (serms).

kot selektivni modulator estrogenskega receptorja (serm) deluje raloksifen bodisi kot selektivni agonist ali kot antagonist na tkiva, ki se odzivajo na estrogen.
as a selective oestrogen receptor modulator (serm), raloxifene has selective agonist or antagonist activities on tissues responsive to oestrogen.

kot selektivni modulator estrogenskega receptorja (serm) deluje raloksifen bodisi kot selektivni agonist bodisi kot antagonist na tkiva, ki se odzivajo na estrogen.
as a selective oestrogen receptor modulator (serm), raloxifene has selective agonist or antagonist activities on tissues responsive to oestrogen.